**Core Concept**
The question refers to the effect of a drug, likely a diuretic, on a non-permeable cell, which is related to **inhibiting the sodium-potassium-chloride cotransporter (NKCC2)** in the thick ascending limb of the loop of Henle. This concept is crucial in understanding **diuretic mechanisms** and their effects on the kidney's ability to concentrate or dilute urine.

**Why the Correct Answer is Right**
Since the correct answer is not provided, let's discuss the general concept. A drug like **furosemide** (a loop diuretic) acts on the NKCC2 cotransporter, preventing sodium, chloride, and potassium reabsorption. This action increases the amount of sodium, chloride, and water in the tubular lumen, leading to increased urine production. The "Annerix V" likely refers to a loop diuretic, given its action on a non-permeable cell, which aligns with the mechanism of loop diuretics.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific details of each option, we cannot directly address why each is incorrect. However, typically, options that do not align with the mechanism of action of loop diuretics on non-permeable cells in the kidney would be incorrect.
**Option B:** Similarly, this would be incorrect if it does not relate to the action of loop diuretics on the kidney.
**Option C:** This option would be wrong if it describes an action not associated with loop diuretics.
**Option D:** Incorrect if it does not match the expected action of a loop diuretic on a non-permeable cell.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that loop diuretics act by **inhibiting the NKCC2 cotransporter**, leading to a significant increase in urine output. This mechanism is crucial for understanding how these drugs are used to treat conditions like **edema** and **hypertension**.

**Correct Answer:** Not provided in the query.